Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls

Proteomics

Volumn 14, Issue 15, 2014, Pages 1713-1723

  Kontro, Hilkka ^a   Joenväärä, Sakari ^a,b   Haglund, Caj ^b,c   Renkonen, Risto ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute pancreatitis; Glycoproteomics; MS; Pancreatic cancer; Sialylation; Technology

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; FETUIN A; GLYCAN; HAPTOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN J; IMMUNOGLOBULIN M; LECTIN; OROSOMUCOID; SIALOGLYCOPROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; GLYCOPEPTIDE; N ACETYLNEURAMINIC ACID;

ACUTE PANCREATITIS; ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SAMBUCUS NIGRA; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; PANCREAS TUMOR; PANCREATITIS;

CASE-CONTROL STUDIES; GLYCOPEPTIDES; HUMANS; N-ACETYLNEURAMINIC ACID; PANCREATIC NEOPLASMS; PANCREATITIS;

EID: 84905248156     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300270     Document Type: Article

References (31)

1. Official Statistics of Finland (OSF), Causes of Death [e-publication], Statistics Finland, Helsinki 2013. Available at: http://www.stat.fi/til/ksyyt/2011/ksyyt_2011_2012-12-21_tie_001_en.html (accessed June 2, 2014).
2. Arnold, J. N., Saldova, R., Hamid, U. M., Rudd, P. M., Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8, 3284-3293.
3. Saldova, R., Fan, Y., Fitzpatrick, J. M., Watson, R. W., Rudd, P. M., Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology 2011, 21, 195-205.
4. Saldova, R., Wormald, M. R., Dwek, R. A., Rudd, P. M., Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers 2008, 25, 219-232.
5. de Leoz, M. L., Young, L. J., An, H. J., Kronewitter, S. R. et al., High-mannose glycans are elevated during breast cancer progression. Mol. Cell. Proteomics 2011, 10, M110.002717.
6. Peracaula, R., Barrabés, S., Sarrats, A., Rudd, P. M., de Llorens, R., Altered glycosylation in tumours focused to cancer diagnosis. Dis. Markers 2008, 25, 207-218.
7. Tian, Y., Zhang, H., Characterization of disease-associated N-linked glycoproteins. Proteomics 2013, 13, 504-11.
8. Zhao, J., Qiu, W., Simeone, D. M., Lubman, D. M., N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J. Proteome Res. 2007, 6, 1126-1138.
9. Zhao, J., Patwa, T. H., Qiu, W., Shedden, K. et al., Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 2007, 6, 1864-1874.
10. Nakano, M., Nakagawa, T., Ito, T., Kitada, T. et al., Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int.l J. Cancer 2008, 122, 2301-2309.
11. Werner, J., Hartwig, W., Uhl, W., Müller, C., Büchler, M. W., Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003, 3, 115-127.
12. Varki, A., Cummings, R., Esko, J., Freeze, H. et al., Essentials of Glycobiology, Cold Spring Harbor, New York 1999.
13. Shibuya, N., Goldstein, I. J., Broekaert, W. F., Nsimba-Lubaki, M. et al., The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262, 1596-1601.
14. Wang, W. C., Cummings, R. D., The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2, 3 to penultimate galactose residues. J. Biol.l Chem. 1988, 263, 4576-4585.
15. Yodoshi, M., Ikuta, T., Mouri, Y., Suzuki, S., Specific extraction of sialic-acid-containing glycans and glycopeptides using serotonin-bonded silica. Anal. Sci. 2010, 26, 75-81.
16. Palmisano, G., Lendal, S. E., Engholm-Keller, K., Leth-Larsen, R. et al., Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry. Nat. Protoc. 2010, 5, 1974-1982.
17. Lohrig, K., Sickmann, A., Lewandrowski, U., Strong cation exchange chromatography for analysis of sialylated glycopeptides. Methods Mol. Biol. 2011, 753, 299-308.
18. Kolli, V., Dodds, E. D., Energy-resolved collision-induced dissociation pathways of model N-linked glycopeptides: implications for capturing glycan connectivity and peptide sequence in a single experiment. Analyst 2014, 139, 2144-2153.
19. Joenväärä, S., Ritamo, I., Peltoniemi, H., Renkonen, R., N-glycoproteomics-an automated workflow approach. Glycobiology 2008, 18, 339-349.
20. Dallas, D. C., Martin, W. F., Hua, S., German, J. B., Automated glycopeptide analysis-review of current state and future directions. Brief. Bioinform. 2013, 14, 361-374.
21. Chandler, K. B., Pompach, P., Goldman, R., Edwards, N., Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search. J. Proteome Res. 2013, 12, 3652-3666.
22. Chelius, D., Bondarenko, P. V., Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J. Proteome Res. 2002, 1, 317-323.
23. Bondarenko, P. V., Chelius, D., Shaler, T. A., Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Chem. 2002, 74, 4741-4749.
24. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteom. 2002, 1, 845-867.
25. Pluskal, T., Castillo, S., Villar-Briones, A., Orešič, M., MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 2010, 11, 395.
26. Chambers, M. C., Maclean, B., Burke, R., Amodei, D. et al., A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 2012, 30, 918-920.
27. Peltoniemi, H., Natunen, S., Ritamo, I., Valmu, L., Räbinä, J., Novel data analysis tool for semiquantitative LC-MS-MS2 profiling of N-glycans. Glycoconjugate J. 2013, 30, 159-170.
28. Sarrats, A., Saldova, R., Pla, E., Fort, E. et al., Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteom. Clin. Appl. 2010, 4, 432-448.
29. Miyoshi, E., Nakano, M., Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 2008, 8, 3257-3262.
30. Miyoshi, E., Shinzaki, S., Moriwaki, K., Matsumoto, H., Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Method. Enzymol. 2010, 153-64.
31. Niemann, M. A., Narkates, A. J., Miller, E. J., Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of alpha 1-antitrypsin from human placenta. Matrix 1992, 12, 233-241.